MedPlus Health Services Limited reported a robust financial performance for the quarter ending December 31, 2024, with significant growth across key metrics driven by higher revenue from operations and efficient cost management.
The company’s total income for Q3 FY25 stood at ₹1,573.96 crore, reflecting an 8.4% YoY increase from ₹1,451.57 crore in Q3 FY24. The growth was primarily supported by higher operational revenue, which increased to ₹1,561.44 crore compared to ₹1,441.72 crore last year.
The net profit for the quarter surged over 240% YoY to ₹45.87 crore, as compared to ₹13.37 crore in the same period last year. This remarkable increase was driven by efficient cost control, especially in inventory and materials management.
Key financial highlights:
- Total expenses for the quarter were ₹1,517.36 crore, up from ₹1,431.01 crore in Q3 FY24, marking a controlled increase of 6.0%.
- Profit before tax (PBT) rose to ₹56.60 crore, significantly higher than ₹19.96 crore in Q3 FY24.
- The company’s tax expense saw some relief due to deferred tax benefits of ₹4.79 crore during the quarter.
For the nine months ending December 31, 2024, total income stood at ₹4,659.27 crore, up from ₹4,163.91 crore for the same period last year, registering a solid growth trajectory.
The company’s strong operational performance, coupled with its focus on cost optimization, has positioned it well to sustain growth and maintain profitability in the coming quarters.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your research or consult a financial advisor before making investment decisions.
